Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 10
2004 12
2005 4
2006 11
2007 14
2008 17
2009 20
2010 32
2011 35
2012 36
2013 41
2014 49
2015 45
2016 57
2017 66
2018 66
2019 57
2020 79
2021 68
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

638 results
Results by year
Filters applied: . Clear all
Page 1
Hallmarks of Aging in the Liver.
Hunt NJ, Kang SWS, Lockwood GP, Le Couteur DG, Cogger VC. Hunt NJ, et al. Among authors: kang sws. Comput Struct Biotechnol J. 2019 Aug 7;17:1151-1161. doi: 10.1016/j.csbj.2019.07.021. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31462971 Free PMC article. Review.
Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
Kim HA, Lee JW, Nam SJ, Park BW, Im SA, Lee ES, Jung YS, Yoon JH, Kang SS, Lee SJ, Park KH, Jeong J, Cho SH, Kim SY, Kim LS, Moon BI, Lee MH, Kim TH, Park C, Jung SH, Gwak G, Kim J, Kang SH, Jin YW, Kim HJ, Han SH, Han W, Hur MH, Noh WC; Korean Breast Cancer Study Group. Kim HA, et al. Among authors: kang sh. J Clin Oncol. 2020 Feb 10;38(5):434-443. doi: 10.1200/JCO.19.00126. Epub 2019 Sep 16. J Clin Oncol. 2020. PMID: 31518174 Clinical Trial.
Obesity, Metabolic Abnormality, and Progression of CKD.
Yun HR, Kim H, Park JT, Chang TI, Yoo TH, Kang SW, Choi KH, Sung S, Kim SW, Lee J, Oh KH, Ahn C, Han SH; Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) Investigators. Yun HR, et al. Am J Kidney Dis. 2018 Sep;72(3):400-410. doi: 10.1053/j.ajkd.2018.02.362. Epub 2018 May 2. Am J Kidney Dis. 2018. PMID: 29728317
Cathepsins: Potent regulators in carcinogenesis.
Khaket TP, Kwon TK, Kang SC. Khaket TP, et al. Among authors: kang sc. Pharmacol Ther. 2019 Jun;198:1-19. doi: 10.1016/j.pharmthera.2019.02.003. Epub 2019 Feb 11. Pharmacol Ther. 2019. PMID: 30763594 Review.
PGE2 vs PGF2Ī± in human parturition.
Li WJ, Lu JW, Zhang CY, Wang WS, Ying H, Myatt L, Sun K. Li WJ, et al. Among authors: sun k. Placenta. 2021 Jan 15;104:208-219. doi: 10.1016/j.placenta.2020.12.012. Epub 2020 Dec 31. Placenta. 2021. PMID: 33429118 Review.
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
Verstovsek S, Mesa RA, Gotlib J, Gupta V, DiPersio JF, Catalano JV, Deininger MW, Miller CB, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner EO, Lyons RM, Paquette R, Raza A, Jones M, Kornacki D, Sun K, Kantarjian H; COMFORT-I investigators. Verstovsek S, et al. Among authors: sun k. J Hematol Oncol. 2017 Feb 22;10(1):55. doi: 10.1186/s13045-017-0417-z. J Hematol Oncol. 2017. PMID: 28228106 Free PMC article. Clinical Trial.
Transcytosis of Nanomedicine for Tumor Penetration.
Liu Y, Huo Y, Yao L, Xu Y, Meng F, Li H, Sun K, Zhou G, Kohane DS, Tao K. Liu Y, et al. Among authors: sun k. Nano Lett. 2019 Nov 13;19(11):8010-8020. doi: 10.1021/acs.nanolett.9b03211. Epub 2019 Oct 25. Nano Lett. 2019. PMID: 31639306
638 results